Both R. intestinalis and butyrate were shown to suppress tumor growth in orthotopic MC38 and CT26 mouse models by activating cytotoxic CD8+ T cells, enhancing the production of granzyme B, IFNγ and TNFα. The gene discussed is CD8A; the disease is neoplasm.